Opening New Frontiers By Advancing The Promise of PI Signaling Pathways
Select a team to find out more
President and Chief Executive Officer
Brian O’Callaghan has more than 25 years of global experience in the biotechnology and pharmaceutical industries spanning five countries and both sides of the U.S.
Brian arrived at Petra Pharma in 2017 after serving as Chairman and Chief Executive Officer of Sonrgy, Inc., a development-stage biotechnology company developing innovative cancer therapies. Previously, he served as President and Chief Executive and a member of the board at Acucela, Inc. Sangart, Inc., and BioPartners, Inc.
Brian has broad experience at public and private companies within Big Pharma, biotechnology and the CRO industries. He has held senior positions at Pfizer, Novartis, Merck Serono, NPS and Covance, and acquired extensive understanding of startups, corporate restructuring, initial public offerings, mergers and acquisitions, business development and fundraising, as well as all levels of company operations from product development to commercialization.
Brian earned a M.B.A. from the Henley College of Business Management at the University of Reading. He currently serves on a number of corporate boards, including BIOCOM, Decoy Biosystems and Aquavit Biopharma, and sits on the board of the San Diego Century Club, a large non-profit organization.